182 related articles for article (PubMed ID: 3570485)
1. [Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
Infection; 1987; 15(1):60-8. PubMed ID: 3570485
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
Infection; 1987; 15 Suppl 2():S51-9. PubMed ID: 3112021
[TBL] [Abstract][Full Text] [Related]
3. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
Pennington JE; Pier GB
Infection; 1987; 15(1):56-9. PubMed ID: 3106230
[TBL] [Abstract][Full Text] [Related]
4. Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo.
Collins MS; Dorsey JH
Am J Med; 1984 Mar; 76(3A):155-60. PubMed ID: 6424444
[TBL] [Abstract][Full Text] [Related]
5. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
Pennington JE; Pier GB
Infection; 1987; 15 Suppl 2():S47-50. PubMed ID: 3112020
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model.
Felts AG; Giridhar G; Grainger DW; Slunt JB
Burns; 1999 Aug; 25(5):415-23. PubMed ID: 10439150
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa: in vivo (murine) activity of five antimicrobial drugs, with and without human IgG immunoglobulin preparations.
Traub WH; Bauer D; Spohr M
Chemotherapy; 1989; 35(1):23-38. PubMed ID: 2498043
[TBL] [Abstract][Full Text] [Related]
8. Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice.
Fomsgaard A; Holder IA
APMIS; 1993 Mar; 101(3):229-34. PubMed ID: 8507460
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
[TBL] [Abstract][Full Text] [Related]
10. Re: Prophylaxis of gram-negative and gram-positive infections in rodents with three intravenous immunoglobulins and therapy of experimental polymicrobial burn wound sepsis with pseudomonas immunoglobulin and ciprofloxacin.
Stephan W; Dichtelmüller H
Infection; 1987; 15(6):463-4. PubMed ID: 3436681
[No Abstract] [Full Text] [Related]
11. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
Collins MS; Roby RE
Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
[TBL] [Abstract][Full Text] [Related]
12. [Serum IgG concentrations and antibody titer of burn patients after preventive intravenous IgG substitution with a Pseudomonas immunoglobulin].
Stuttmann R; Hartert M; Jahn M; Spilker G; Doehn M
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():48-55. PubMed ID: 8499751
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.
Cryz SJ; Fürer E; Sadoff JC; Fredeking T; Que JU; Cross AS
J Infect Dis; 1991 May; 163(5):1055-61. PubMed ID: 1902245
[TBL] [Abstract][Full Text] [Related]
14. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
Antibiot Chemother (1971); 1987; 39():222-32. PubMed ID: 3118784
[No Abstract] [Full Text] [Related]
15. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
[TBL] [Abstract][Full Text] [Related]
16. [Prevention using a Pseudomonas immunoglobulin in burn patients].
Stuttmann R; Petrovici V; Hartert M
Infection; 1987; 15(1):80-4. PubMed ID: 3106234
[TBL] [Abstract][Full Text] [Related]
17. Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient.
Baumgartner JD; Glauser MP
Rev Infect Dis; 1987; 9(1):194-205. PubMed ID: 3547572
[TBL] [Abstract][Full Text] [Related]
18. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
Faezi S; Sattari M; Mahdavi M; Roudkenar MH
Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
20. Study of the protective effects of hyperimmune immunoglobulins G and M against endotoxin in mice and rats.
Nys M; Damas J; Damas P; Laub R; Cloes JM; Lamy M
Med Microbiol Immunol; 1999 Nov; 188(2):55-64. PubMed ID: 10753056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
